Lilly World's Best-Selling Drug: Is the Stock a Buy Now?
Eli Lilly's ascent to the top of the drug charts centers on a single family of medicines. This article breaks down wh...
Reducing expenses is essential for better budgeting. Explore effective strategies to cut costs and enhance your savings potential.
20,311 articlesEli Lilly's ascent to the top of the drug charts centers on a single family of medicines. This article breaks down wh...
Canadian traders face a fast-moving market in May 2026 as platforms race to lower costs and boost real-time data. Thi...
Investors are flocking to space names as Rocket Lab reports a record quarter and solid Q2 guidance. Here’s what this ...
Netflix reports revenue growth driven by ads and a leaner strategy, while Disney posts margins and park revenue gains...
As tariffs and a stronger dollar shape markets, IDV’s 4.7% yield just proved its income stream can endure, even as qu...
The T3 Financial Crime Unit, supported by tether, tron labs-backed financial partners, says it has frozen over $450 m...
Global markets sold off after leaders offered little concrete trade progress. Investors warn that day one of talks ma...
DoorDash is down about 30% year-to-date as Amazon climbs about 14%, illustrating a widening gap between pure-delivery...
Growth-focused SPYG has outpaced SPYV over the last decade, a trend supported by AI spending and mega-cap tech. The g...
AI projects are stalling in many firms despite heavy investment, prompting Fortune’s Workplace Innovation Summit to p...
AI-driven momentum puts Apple on a path to a potential $6 trillion valuation, as investors weigh WWDC 2026 plans and ...
As Congress let enhanced marketplace tax credits lapse, buyers are increasingly eyeing cheaper, alternative health pl...